A CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF KARPASASTHYADI TAILA NASYAKARMA IN THE MANAGEMENT OF GREEVA ASTHIGATAVATA VIS- A-VIS CERVICAL SPONDYLOSIS

Abstract

Asthigatavata is one among Shoola and Shosha Pradhana Vatavyadhi characterized by Asthishosha (Osteoporosis), Asthibheda (Cutting pain in bony joints), Asthishoola, Sandhishoola (Joint pain), Bedhaasthiparvanam (Splitting pain in bones and joints), Mamsabalakshaya (Loss of muscle strength), Aswapna (Insomnia) and Satata Ruk (Continuous pain). When Kupitha Vata Dosha enters in to the Asthi present in Greevapradesha causes series of changes producing symptoms and this clinical entity is named as Greeva Asthigatavata. Cervical Spondylosis is seen in the general population with the incidence rate of 83 per 100,000 and occurs mostly in fourth and fifth decades of life. More disability is seen over the age of 50years. Its prevalence is similar for both the sex, although the degree of severity is greater for males. Aim: To evaluate the therapeutic efficacy of Karpasasthyadi Taila Nasyakarma in the management of Greeva Asthigatavata vis-à-vis Cervical Spondylosis. Materials and Methods: It was a controlled clinical study with pre and posttest design. Total 100 subjects were incidentally selected and assigned into two groups viz., Group A (Control group) and Group B (Test group), with 50 subjects in each group. Subjects of Control Group were subjected with Greevabasti with Mahamasha Taila for 7 consecutive days and Astavarga Kashaya internally for 14 consecutive days from the first day of Greevabasti. Subjects of Test Group were subjected to Nasyakarma with Karpasasthyadi Taila for 7 consecutive days along with Greevabasti with Mahamasha Taila for 7 consecutive days and Astavarga Kashaya internally for 14 consecutive days from the first day of Nasyakarma. The study consisted of 3 assessments i.e on 0th day, 7th day and on 14th day. Result: In the study it was observed that Group B (CC=0.529) showed clinically and statistically highly significant results with respect to reduction of symptoms than Group A (CC=0.389) with high contingency coefficient value. Also, the overall assessment showed clinically and statistically highly significant result in both groups with p value 0.000. Conclusion: On comparing the overall effect of the study, trial group (Group B) showed better results than control group (Group A). Hence, Karpasasthyadi Taila has a better role in the management of Greeva Asthigatavata.